Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Inhalation | 6 | 2014 | 18 | 0.500 |
Why?
|
| Isoflurane | 5 | 2013 | 16 | 0.380 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 162 | 0.350 |
Why?
|
| Oxygen | 4 | 2009 | 316 | 0.310 |
Why?
|
| Animals, Newborn | 9 | 2014 | 237 | 0.310 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 447 | 0.300 |
Why?
|
| Hypoxia-Ischemia, Brain | 3 | 2014 | 9 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 3 | 2009 | 178 | 0.260 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 660 | 0.250 |
Why?
|
| Hypothermia, Induced | 3 | 2014 | 40 | 0.220 |
Why?
|
| Fever | 1 | 2024 | 65 | 0.220 |
Why?
|
| Apoptosis | 4 | 2013 | 1073 | 0.220 |
Why?
|
| Methyl Ethers | 2 | 2014 | 7 | 0.210 |
Why?
|
| Neurons | 5 | 2013 | 921 | 0.180 |
Why?
|
| Mitochondria | 1 | 2024 | 370 | 0.170 |
Why?
|
| Sepsis | 1 | 2024 | 279 | 0.170 |
Why?
|
| Brain | 4 | 2014 | 1555 | 0.170 |
Why?
|
| Pemetrexed | 1 | 2019 | 11 | 0.160 |
Why?
|
| Bevacizumab | 1 | 2019 | 59 | 0.160 |
Why?
|
| Brain Injuries | 3 | 2009 | 139 | 0.130 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2005 | 57 | 0.120 |
Why?
|
| Swine | 6 | 2009 | 370 | 0.110 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2006 | 26 | 0.110 |
Why?
|
| Maze Learning | 2 | 2014 | 55 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 259 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2009 | 230 | 0.080 |
Why?
|
| Oxygen Consumption | 2 | 2024 | 209 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 41 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2009 | 72 | 0.070 |
Why?
|
| Memory | 1 | 2009 | 119 | 0.070 |
Why?
|
| Heart Rate | 2 | 2006 | 321 | 0.070 |
Why?
|
| Animals | 11 | 2014 | 20649 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 3394 | 0.070 |
Why?
|
| Carbon Dioxide | 2 | 2009 | 86 | 0.060 |
Why?
|
| Oximetry | 1 | 2006 | 48 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2006 | 509 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2006 | 44 | 0.060 |
Why?
|
| Electroencephalography | 2 | 2009 | 147 | 0.060 |
Why?
|
| Male | 8 | 2024 | 29603 | 0.060 |
Why?
|
| Celecoxib | 1 | 2005 | 13 | 0.060 |
Why?
|
| Respiration | 1 | 2006 | 89 | 0.060 |
Why?
|
| Taxoids | 1 | 2005 | 26 | 0.060 |
Why?
|
| Female | 8 | 2024 | 32597 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 174 | 0.060 |
Why?
|
| Citrate (si)-Synthase | 1 | 2024 | 5 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 242 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2005 | 78 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2005 | 126 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2005 | 368 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 87 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 242 | 0.050 |
Why?
|
| Partial Pressure | 1 | 2002 | 9 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2002 | 75 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2002 | 106 | 0.050 |
Why?
|
| Caspase 3 | 2 | 2013 | 109 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2002 | 245 | 0.050 |
Why?
|
| Algorithms | 1 | 2006 | 1001 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1114 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2003 | 169 | 0.040 |
Why?
|
| Mice | 5 | 2014 | 10839 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2002 | 292 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 892 | 0.040 |
Why?
|
| Maintenance Chemotherapy | 1 | 2019 | 15 | 0.040 |
Why?
|
| Carboplatin | 1 | 2019 | 43 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1638 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2019 | 99 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2024 | 1974 | 0.040 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 46 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 490 | 0.040 |
Why?
|
| Cell Survival | 2 | 2009 | 573 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 3263 | 0.030 |
Why?
|
| Aged | 2 | 2019 | 14281 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1079 | 0.030 |
Why?
|
| Time Factors | 3 | 2009 | 3748 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2002 | 1293 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 17416 | 0.030 |
Why?
|
| Child | 1 | 2024 | 4487 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 172 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2005 | 5606 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 2188 | 0.030 |
Why?
|
| Adolescent | 1 | 2024 | 6193 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2013 | 22 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2013 | 19 | 0.030 |
Why?
|
| Interneurons | 1 | 2013 | 22 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2013 | 40 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 75 | 0.020 |
Why?
|
| Humans | 3 | 2024 | 62942 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 455 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 41 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2011 | 34 | 0.020 |
Why?
|
| Colorimetry | 1 | 2011 | 25 | 0.020 |
Why?
|
| Cognition | 1 | 2014 | 480 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 144 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 1196 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 75 | 0.020 |
Why?
|
| Adult | 1 | 2005 | 16669 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 455 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2006 | 75 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 483 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1080 | 0.020 |
Why?
|
| Motor Activity | 1 | 2009 | 346 | 0.020 |
Why?
|
| Rewarming | 1 | 2005 | 6 | 0.020 |
Why?
|
| Survival | 1 | 2005 | 12 | 0.020 |
Why?
|
| Glucose | 1 | 2009 | 470 | 0.020 |
Why?
|
| Body Temperature | 1 | 2005 | 45 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2005 | 52 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 348 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1142 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1641 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 863 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 2156 | 0.010 |
Why?
|